Results 1 to 10 of about 4,373 (200)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment [PDF]

open access: yesNeuropsychiatric Disease and Treatment, 2022
Robert M Pascuzzi, Cynthia L Bodkin Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USACorrespondence: Robert M Pascuzzi, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, 46202, USA ...
Robert M Pascuzzi
exaly   +4 more sources

Late onset cerebellar ataxia syndrome after non-paraneoplastic Lambert-Eaton myasthenic syndrome: a case study. [PDF]

open access: yesBMC Neurol
This is an unusual case of voltage gated calcium channel (VGCC) antibodies leading to two distinct and chronologically separated neurologic syndromes without the presence of an underlying neoplasm.
Randall DP, Randall MC.
europepmc   +3 more sources

Lambert-Eaton myasthenic syndrome with primary thymic marginal zone B-cell lymphoma: A case report. [PDF]

open access: yesRespirol Case Rep, 2023
Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune paraneoplastic syndrome with proximal muscle weakness, that often complicates small cell lung cancer.
Soma T   +3 more
europepmc   +2 more sources

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan. [PDF]

open access: yesBMJ Neurol Open, 2022
Background There was no nationwide epidemiological study of Lambert-Eaton myasthenic syndrome (LEMS) in Japan; therefore, we conducted a nationwide survey.Methods For the first survey, we sent survey sheets to randomly selected medical departments (n ...
Yoshikawa H   +10 more
europepmc   +2 more sources

Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report. [PDF]

open access: yesRadiol Case Rep, 2023
Spontaneous regression (SR) of cancer is very rare, especially of small cell lung cancer (SCLC). Recently, an association of paraneoplastic neurological syndrome (PNS) has been reported as a cause of SR of cancer, and onconeural antibodies are a possible
Otani M   +17 more
europepmc   +2 more sources

Lambert-Eaton myasthenic syndrome presenting with occult mediastinal small cell carcinoma and positivity for anti-CV2/CRMP5 and anti-SOX1 antibodies: a case report. [PDF]

open access: yesBMC Neurol
Background Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune neuromuscular disorder characterized by proximal muscle weakness, autonomic dysfunction and hyporeflexia.
Wang A, Li H, Li D, Wang K, Zhang L.
europepmc   +2 more sources

The Case of a 28‐Year‐Old Man With Gradually Progressive Proximal Leg Weakness

open access: yesAnnals of Clinical and Translational Neurology
This is a case of a 28‐year‐old man who presented with a 6‐month history of gradually progressive proximal leg weakness and pain that worsened on exercise and was relieved by rest. He had no symptoms in his upper limbs.
Melody T. Asukile   +3 more
doaj   +2 more sources

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome. [PDF]

open access: yesRespir Med Case Rep
Lambert-Eaton myasthenic syndrome (LEMS) is a rare disease but is often associated with small-cell lung cancer (SCLC). We discuss the case of a 65-year-old man diagnosed with SCLC-LEMS and treated with carboplatin, etoposide, and durvalumab.
Ishibashi N   +7 more
europepmc   +2 more sources

SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: A case report. [PDF]

open access: yesClin Respir J
Lambert–Eaton myasthenic syndrome (LEMS) is a rare paraneoplastic neurological syndrome of the neuromuscular transmission. The symptoms often progress slowly and can be misdiagnosed in early stage.
Zhao L   +5 more
europepmc   +2 more sources

Atypical Presentation of Seronegative Paraneoplastic Lambert-Eaton Myasthenic Syndrome with Cerebellar Ataxia. [PDF]

open access: yesAnn Indian Acad Neurol
Rohatgi S   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy